City’s vaccine czar: 140K individuals in Mandaue first to get COVID shots
MANDAUE CITY, Philippines — About 140,000 individuals in Mandaue city would be the first to receive the COVID-19 vaccine from the national government.
Subangdaku Barangay Captain Ernie Manatad, chairman of the Mandaue City COVID-19 Vaccine Board and president of the Association of Barangay Councils in Mandaue City, said that this was based on the list they had made in accordance with the national government’s guidelines.
Read: Mandaue forms COVID-19 vaccine board
Leading the list are city health workers and hospital medical workers then other frontliners such as those in the barangay, followed by indigents, then senior citizens, and uniformed personnel.
Read: LIST: Priority groups for government’s Covid-19 vaccination program
According to Lawyer John Eddu Ibañez, executive secretary of Mayor Jonas Cortes, the city’s population is 362,700 based on the 2015 census.
The city has allotted P200 million to procure COVID-19 vaccines for residents, who will not be included in the allotted vaccines from the national government.
Read: Mandaue City sets aside P200M for COVID-19 vaccine
Manatad said they had yet to talk to any COVID-19 vaccine manufacturer.
He said that they would coordinate with the DOH in purchasing COVID-19 vaccines, but the Mandaue City Chamber of Commerce and Industry (MCCI) was also looking at any access to where the city could directly purchase COVID-19 vaccines.
Moreover, the city has already started its online registration.
Manatad said the city health workers had already registered online and that they would soon roll out the registration process in the barangays.
The Management Information System Office (MISO) has made a local link for pre-registration.
He said it would be transferred to the Department of Health (DOH) registration system when the DOH’s link would be available. /dbs
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.